tiprankstipranks
Advertisement
Advertisement
C Ray Therapeutics Emphasizes Integrated Radiopharmaceutical Development and Isotope Supply
PremiumPrivate CompaniesC Ray Therapeutics Emphasizes Integrated Radiopharmaceutical Development and Isotope Supply
6d ago
C Ray Therapeutics Highlights Growing Radiopharmaceutical CRDMO Platform and Isotope Supply Capabilities
Premium
Private Companies
C Ray Therapeutics Highlights Growing Radiopharmaceutical CRDMO Platform and Isotope Supply Capabilities
6d ago
C Ray Therapeutics Steps Up Global Radiopharmaceutical Outreach Ahead of Key 2026 Conferences
Premium
Private Companies
C Ray Therapeutics Steps Up Global Radiopharmaceutical Outreach Ahead of Key 2026 Conferences
19d ago
C Ray Therapeutics Targets Strategic Engagement at SNMMI 2026 in Radiopharmaceuticals
PremiumPrivate CompaniesC Ray Therapeutics Targets Strategic Engagement at SNMMI 2026 in Radiopharmaceuticals
25d ago
C Ray Therapeutics Secures FDA-Active Cu-64 DMF and Expands Global Radiopharma CRDMO Role
Premium
Private Companies
C Ray Therapeutics Secures FDA-Active Cu-64 DMF and Expands Global Radiopharma CRDMO Role
1M ago
C Ray Therapeutics Highlights FDA-Listed Cu-64 DMF and Radiopharmaceutical Platform
Premium
Private Companies
C Ray Therapeutics Highlights FDA-Listed Cu-64 DMF and Radiopharmaceutical Platform
1M ago
C Ray Therapeutics Showcases Radiopharma CRDMO Strength Ahead of ANZSNM2026
PremiumPrivate CompaniesC Ray Therapeutics Showcases Radiopharma CRDMO Strength Ahead of ANZSNM2026
1M ago
C Ray Therapeutics Highlights Radiopharma Capabilities Ahead of ANZSNM2026
Premium
Private Companies
C Ray Therapeutics Highlights Radiopharma Capabilities Ahead of ANZSNM2026
1M ago
C Ray Therapeutics Highlights Radiopharma CRDMO Capabilities and ANZSNM2026 Presence
Premium
Private Companies
C Ray Therapeutics Highlights Radiopharma CRDMO Capabilities and ANZSNM2026 Presence
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100